Sustained hypoglycemia with therapeutic use of repaglinide.

Hantson, Philippe;El Balkhi, Souleiman;Haufroid, Vincent;Laterre, Pierre-François
(2020) Acta Diabetologica : an international journal devoted to the study of clinical and experimental diabetes and metabolism — Vol. 57, p. 751-753 (2020)

Files

2019_Hantson_Acta_Diabetol.pdf
  • Open Access
  • Adobe PDF
  • 162.98 KB
Download

Details

Authors
Abstract
Repaglinide is a short-acting insulin secretagogue used for the reduction in postprandial glucose levels in diabetic patients. It has a favorable safety profile with a low risk of hypoglycemia. Prolonged hypoglycemia appears exceptional due to the short serum elimination half-life. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hantson, P., El Balkhi, S., Haufroid, V., & Laterre, P.-F. (2020). Sustained hypoglycemia with therapeutic use of repaglinide. Acta Diabetologica : an international journal devoted to the study of clinical and experimental diabetes and metabolism, 57, 751-753. https://doi.org/10.1007/s00592-019-01456-w (Original work published 2020)